1.De Angelis, R., et al., Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5—a population-based study. The Lancet Oncology, 2014. 15(1): p. 23–34.
2.Jemal, A., et al., Global cancer statistics. CA Cancer J Clin, 2011. 61(2): p. 69–90.
3.Bosetti, C., et al., The decline in breast cancer mortality in Europe: an update (to 2009). Breast, 2012. 21(1): p. 77–82.
4.Ferlay, J., et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015. 136(5): p. E359–86.
5.Berger, A.M., et al., Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage, 2007. 33(4): p. 398–409.
6.Savard, J., et al., Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep, 2001. 24(5): p. 583–90.
7.Savard, J., et al., Insomnia in men treated with radical prostatectomy for prostate cancer. Psychooncology, 2005. 14(2): p. 147–56.
8.Savard, J., et al., Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol, 2009. 27(31): p. 5233–9.
9.Carpenter, J. S., et al., Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum, 2004. 31(3): p. 591–5598.
10.Palesh, O. G., et al., Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol, 2010. 28(2): p. 292–8.
11.Sanford, S. D., et al., Longitudinal prospective assessment of sleep quality: before, during, and after adjuvant chemotherapy for breast cancer. Support Care Cancer, 2013. 21(4): p. 959–67.
12.Enderlin, C. A., et al., Sleep across chemotherapy treatment: a growing concern for women older than 50 with breast cancer. Oncol Nurs Forum, 2010. 37(4): p. 461-a3.
13.Beck, S. L., et al., Sleep quality after initial chemotherapy for breast cancer. Support Care Cancer, 2010. 18(6): p. 679–89.
14.Savard, J., et al., Cancer treatments and their side effects are associated with aggravation of insomnia: Results of a longitudinal study. Cancer, 2015. 121(10): p. 1703–11.
15.Chen, M. L., C. T. Yu, and C. H. Yang, Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy. Lung Cancer, 2008. 62(3): p. 391–400.
16.Van Onselen, C., et al., Trajectories of sleep disturbance and daytime sleepiness in women before and after surgery for breast cancer. J Pain Symptom Manage, 2013. 45(2): p. 244–60.
17.Ho, R. T. and T. C. Fong, Factor structure of the Chinese version of the Pittsburgh sleep quality index in breast cancer patients. Sleep Med, 2014. 15(5): p. 565–9.
18.Buysse, D. J., et al., The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res, 1989. 28(2): p. 193–213.
19.Lee, B. N., et al., A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation, 2004. 11(5): p. 279–92.
20.Mills, P. J., et al., The effects of standard anthracycline-based chemotherapy on soluble ICAM–1 and vascular endothelial growth factor levels in breast cancer. Clin Cancer Res, 2004. 10(15): p. 4998–5003.
21.Payne, J., et al., Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study. Oncol Nurs Forum, 2006. 33(4): p. 775–83.
22.Wood, L. J., et al., Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines. Oncol Nurs Forum, 2006. 33(3): p. 535–42.
23.Niiranen, A. and K. Mattson, Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy. Am J Clin Oncol, 1987. 10(4): p. 325–9.